Which funds bought or sold CSGP in Q3 2026?
Costar Group Inc. 2 funds bought, 6 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was −$156M.
Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)
- Millennium+$270M
- GlenviewNEW+$290K
- Vanguard−$126M
- Baillie Gifford−$49M
- Polen−$42M
- Legal & General−$26M
- Akre−$24M
- PRIMECAP−$15M
Top 10 each side. NEW = opened a position, OUT = sold the whole position.
Bought (2)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| Millennium Quant & multi-strategy | Added+1318.6% | +$270M | $290M |
| Glenview Hedge fund | New | +$290K | $290K |
Sold (6)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| Vanguard Index giant | Trimmed-12.1% | −$126M | $913M |
| Baillie Gifford Growth / crossover | Trimmed-13.5% | −$49M | $312M |
| Polen Growth / crossover | Trimmed-17.5% | −$42M | $198M |
| Legal & General Asset manager | Trimmed-57% | −$26M | $20M |
| Akre Value investor | Trimmed-7.6% | −$24M | $296M |
| PRIMECAP Growth / crossover | Trimmed-64.7% | −$15M | $8M |
Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.